Johns Hopkins scientists prep PhI combo study for ovarian cancer; Maryland investigator finds flu 'decoy';

> Johns Hopkins scientists say that Rigel's experimental drug fostamatinib could help overcome ovarian cancer cells' resistance to paclitaxel. And now they are planning a Phase I study to test the theory in humans. Release

> A University of Maryland School of Medicine researcher says he has found a "decoy" molecule that can help prevent a runaway immune response to the flu virus. Release

> Scientists from the Florida campus of The Scripps Research Institute say they have found that microRNA plays "surprisingly different roles in the formation of memory in animal models. In some cases, these RNAs increase memory, while others decrease it." Release

Suggested Articles

Brigham and Women’s Hospital scientists linked a noncoding RNA to atherosclerosis in a discovery that could aid in the development of new heart drugs.

Researchers discovered that inactivating a subtype of the protein beta-arrestin-2 in mice restored the ability of the brain to dispose of toxic tau.

A newfound link between BMAL1, a protein involved in circadian rhythms, and triple-negative breast cancer could point to new treatment strategies.